Introduction
1.	Table 1A. ATP III: Assessing CHD Risk in Men Table 1B. ATP III: Assessing CHD Risk in Women Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 2001. NIH Publication 01-3095.
2.	Table 2. Guide to Primary Prevention of Cardiovascular Disease and Stroke: Risk Intervention Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 update. Circulation. 2002;106:388-391. (Updated and modified from original publication to include JNC 7 recommendations; Grundy SM, Cleeman Jl, Merz CNB, et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.)
3.	Table 3. Guideline or Consensus Statement Management Recommendations for Primary Prevention of Ischemic Stroke Goldstein LB, Adams R, Becker K, et al. Primary Prevention of Ischemic Stroke: A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Circulation. 2001;103:163-182. (Updated and modified from original publication to include Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update. Circulation. 2002;106:388-391; Grundy SM, Cleeman Jl, Merz CNB, et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.; Updated with: Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006;113:e873-e923.)
4.	Table 4. AHA/ACC Secondary Prevention for Patients With Coronary and Other Vascular Disease: 2006 Update Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Circulation. 2006;113:2363-2372.
5.	Table 5. Guide to Risk Reduction for Women Mosca L, Grundy SM, Judelson D, et al. Guide to Preventive Cardiology for Women. Circulation. 1999;99:2480-2484. (Updated and modified from original publication to include JNC 7 recommendations; Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update. Circulation. 2002;106:388-391; Mosca L, Appel LJ, Benjamin EJ, et al. AHA Guidelines. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women. Circulation. 2004;109:672-693 ; Grundy SM, Cleeman Jl, Merz CNB, et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239. Mosca L, Banka CL, Benjamin EJ, et al, for the Expert Panel/Writing Group. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update. Circulation. 2007;115:1481-1501).
6.	Table 6. Smoking Cessation Strategies The Agency for Health Care Policy and Research. Treating Tobacco Use and Dependence. US Department of Health and Human Services. Public Health Services Report. June 2000.
7.	Table 7A. ATP III: Nutritional Components of the TLC Diet Table 7B. Summary of Diet and Lifestyle Recommendations from the American Heart Association Nutrition Committee 2006 Table 7C. USDA Dietary Guidelines for Americans Figure 7. Food Guide Pyramid •   Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 2001. NIH Publication 01-3095. •   Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82-96. •   Dietary Guidelines for Americans 2005. US Department of Health and Human Services. Available at http://www.healthierus.gov/dietaryguidelines. Accessed on February 14, 2005. •   Food Guide Pyramid. U.S. Department of Agriculture and the U.S. Department of Health and Human Services. Available at: http://www.nal.usda.gov/fnic/Fpyr/pyramid.html#q2. Accessed on April 15, 2002.
8.	Table 8A. JNC 7 Classification of Blood Pressure for Adults ≥18 Years Old Table 8B. JNC 7 Classification and Management of Blood Pressure for Adults Table 8C. JNC 7: Guideline Basis for Compelling Indications for Individual Drug Classes The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute. 2003; NIH Publication 03-5231.
9.	Table 9A. ATP III: LDL-C Treatment Cutpoints for Therapy Table 9B. ATP III: Risk Categories, LDL-C Goals Table 9C. ATP III: Nutritional Components of the TLC Diet Table 9D. Drugs Affecting Lipoprotein Metabolism Figure 9A. Procedure for Implementing Therapeutic Lifestyle Changes (TLC) Figure 9B. Procedure for Implementing Drug Therapy to Treat Lipid Abnormalities Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 2001. NIH Publication 01-3095. (Updated and modified from original publication to include Grundy SM, Cleeman Jl, Merz CNB, et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.Circulation. 2004;110:227-239.)
10.	Table 10A. ATP III: The Metabolic Syndrome Table 10B. Lifestyle Risk Factors for Metabolic Syndrome and Therapeutic Recommendations Table 10C. Metabolic Risk Factors for Metabolic Syndrome and Therapeutic Recommendations Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 2001. NIH Publication 01-3095. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association and National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112. Epub 2005 Sept 12.
11.	Table 11. Guide to Primary Prevention of Cardiovascular Disease in Patients With Diabetes Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and Cardiovascular Disease: A Statement for Healthcare Professionals from the American Heart Association. Circulation. 1999;100:1134-1146. (Updated and modified from original publication to include Pearson TA et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update. Circulation. 2002;106:388-391; Grundy SM, Cleeman Jl, Merz CNB, et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2005;28(suppl 1):S4-S86.)
12.	Table 12. Strength-Training Standards, Guidelines, and Position Statements Pollock ML, Franklin BA, Balady GJ, et al. Resistance Exercise in Individuals With and Without Cardiovascular Disease: Benefits, Rationale, Safety, and Prescription. An Advisory From the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation. 2000;101:828-833.
13.	Table 13. Classification of Overweight/Obesity by Body Mass Index, Waist Circumference, and Associated Disease Risk Figure 13. Treatment Algorithm for Overweight and Obese Patients National Heart, Lung, and Blood Institute. Obesity Education Initiative Expert Panel. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report 1998. NIH Publication 98-4083.
14.	Table 14. Estimates of Benefits and Harms of Aspirin Given for 5 Years to 1000 Persons with Various Levels of Baseline Risk for Coronary Heart Disease US Preventive Services Task Force. Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale. Ann Intern Med. 2002;136:157-160.
15.	Table 15. Minimum and Additional Clinical Evaluation in Patients With Atrial Fibrillation Figure 15A. Antiarrhythmic Drug Therapy to Maintain Sinus Rhythm in Patients With Recurrent Paroxysmal or Persistent Atrial Fibrillation Figure 15B. Pharmacological Management of Patients with Newly Discovered Atrial Fibrillation Figure 15C. Pharmacological Management of Patients with Recurrent Persistent or Permanent Atrial Fibrillation Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2001;22:1852-1923.
16.	Table 16A. Guidelines for Cardiovascular Health Promotion in All Children and Adolescents Kavey REW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood. Circulation. 2003;107:1562-1566. Table 16B. Daily Estimated Calories and Recommended Servings for Grains, Fruits, Vegetables, and Milk/Dairy Gidding SS, Dennison BA, Birch LL, et al. Dietary recommendations for children and adolescents: a guide for practitioners. Consensus statement from the American Heart Association. Circulation. 2005;112:2061-2075. Table 16C. Tips for Parents to Implement AHA Pediatric Dietary Guidelines Gidding SS, Dennison BA, Birch LL, et al. Dietary recommendations for children and adolescents: a guide for practitioners. Consensus statement from the American Heart Association. Circulation. 2005;112:2061-2075. Figure 16. Food Guide Pyramid for Young Children Food Guide Pyramid for Young Children. U.S. Department of Agriculture and the U.S. Available at: http://www.usda.gov/cnpp/KidsPyra/. Accessed on September 29, 2005.
17.	Table 17. Guide to Improving Cardiovascular Health at the Community Level Pearson TA, Bazzarre TL, Daniels SR, et al. American Heart Association Guide for Improving Cardiovascular Health at the Community Level: A Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers From the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003;107:645-651.
18.	Table 18. Guide to Cardiovascular Risk Reduction in Patients with Peripheral Arterial Disease (PAD) Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic)—Executive Summary. J Am Coll Cardiol. 2006:47;ahead of print.